A Study Evaluating the Long-term Safety of VX-445 Combination Therapy

Clinical trial NCT04043806 · COMPLETED

Trial details

NCT number: NCT04043806
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2019-08-09
Primary completion: 2022-12-14
Enrollment: 458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.